nach oben

Virchows Archiv

Erschienen in:

01.05.2009 | Original Article

Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma

verfasst von: C. Uzan, E. Darai, A. Valent, O. Graesslin, A. Cortez, R. Rouzier, P. Vielh

Erschienen in: Virchows Archiv | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

A role for the EGF system, in particular HER1 and 2, in growth of the endometrium has been suggested but HER1 and 2 have not been studied in all locations of endometriosis and in ovarian endometrioid adenocarcinoma (OEC) which is a rare form of malignant transformation of endometriosis. Immunohistochemistry (IHC) was used for studying HER1 and HER2 in ovarian (n = 10), peritoneal (n = 10), colorectal endometriosis (n = 20) and OEC (n = 10). Fluorescent in situ hybridisation (FISH) was used for analysing the status of HER2 gene in colorectal endometriosis and OEC. All samples were negative for HER2 in both glandular and stromal cells and in glandular cells for HER1 by IHC. In 15 out of 20 colorectal endometriosis, there was a weak expression in stromal cells. Following FISH, two colorectal samples had a partial 17 aneusomy and three OEC, a 17 polysomy. The other samples were 17 disomic without HER2 amplification; HER1 and 2 do not seem to have a role in endometriosis physiopathology.

Casalini P, Iorio MV, Galmozzi E et al (2004) Role of HER receptors family in development and differentiation. J Cell Physiol 200:343–350PubMedCrossRef

Bhargava R, Gerald WL, Li AR et al (2005) EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol 18:1027–1033PubMedCrossRef

Pérez-Soler R (2004) HER1/EGFR targeting: refining the strategy. Oncologist 9:58–67PubMedCrossRef

Brumm C, Rivière A, Wilckens C et al (1990) Immunohistochemical investigation and northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri. Virchows Arch A Pathol Anat Histopathol 417:477–484PubMedCrossRef

Press MF, Cordon-Cardo C, Slamon DJ (1990) Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 5:953–962PubMed

Wang DP, Fujii S, Konishi I et al (1992) Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta. Virchows Arch A Pathol Anat Histopathol 420:385–393PubMedCrossRef

Ejskjaer K, Sørensen BS, Poulsen SS et al (2005) Expression of the epidermal growth factor system in human endometrium during the menstrual cycle. Mol Hum Reprod 11:543–551PubMedCrossRef

Niikura H, Sasano H, Kaga K et al (1996) Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Hum Pathol 27:282–289PubMedCrossRef

Ejskjaer K, Sørensen BS, Poulsen SS et al (2007) Expression of the epidermal growth factor system in endometrioid endometrial cancer. Gynecol Oncol 104:158–167PubMedCrossRef

10.

Stovall DW, Bowser LM, Archer DF et al (1997) Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain. Fertil Steril 68:13–18PubMedCrossRef

11.

Vercellini P, Trespidi L, De Giorgi O et al (1996) Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 65:299–304PubMed

12.

Jenkins S, Olive DL, Haney AF (1986) Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol 67:335–338PubMed

13.

Dubernard G, Piketty M, Rouzier R et al (2006) Quality of life after laparoscopic colorectal resection for endometriosis. Hum Reprod 21:1243–1247PubMedCrossRef

14.

Vigano P, Somigliana E, Chiodo I et al (2006) Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Human Reprod Update 12:77–89CrossRef

15.

Hsieh YY, Chang CC, Tsai FJ et al (2005) T homozygote, allele of epidermal growth factor receptor 2073 gene polymorphism are associated with higher susceptibility to endometriosis and leiomyomas. Fertil Steril 83:796–799PubMedCrossRef

16.

Melega C, Balducci M, Bulletti C et al (1991) Tissue factors influencing growth and maintenance of endometriosis. Ann N Y Acad Sci 622:256–265PubMedCrossRef

17.

Nasu K, Hayata T, Takai N et al (1995) Immunohistochemical study of c-erb B-2 protein expression in endometriosis. Hum Reprod 10:935–937PubMed

18.

Schneider J, Jimenez E, Rodriguez F et al (1998) c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis. Oncol Rep 5:49–52PubMed

19.

Marwah N, Bansal C, Gupta S et al (2007) Immunohistochemical study of the expression of HER-2/neu oncogene in ovarian lesions. Indian J Pathol Microbiol 50:489–492PubMed

20.

Berek JS, Schultes BC, Nicodemus CF (2003) Biologic and immunologic therapies for ovarian cancer. J Clin Oncol 21:168–174CrossRef

21.

Malamou-Mitsi V, Crikoni O, Timotheadou E (2007) Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer. Anticancer Res 27:1157–1165PubMed

22.

Sasaki N, Kudoh K, Kita T et al (2007) Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma. J Obstet Gynaecol Res 33:17–23PubMedCrossRef

23.

Tubbs RR, Pettay JD, Roche PC et al (2001) Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message. J Clin Oncol 19:2714–2721PubMed

24.

Gong Y, Yan K, Lin F et al (2007) Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. Lancet Oncol 8:203–211PubMedCrossRef

25.

Inagaki M, Yoshida S, Kennedy S et al (2007) Association study between epidermal growth factor receptor and epidermal growth factor polymorphisms and endometriosis in a Japanese population. Gynecol Endocrinol 24:1–5

26.

Tuefferd M, Couturier J, Penault-Llorca F et al (2007) HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients. PLoS ONE 2:1138CrossRef

27.

Noack F, Schmidt H, Buchweitz O (2004) Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst. Anticancer Res 24:151–154PubMed

28.

Bunn PA Jr, Dziadziuszko R, Varella-Garcia M et al (2006) Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy. Clin Cancer Res 12:3652–3656PubMedCrossRef

29.

Li AR, Chitale D, Riely GJ et al (1995) Immunohistochemical study of c-erb B-2 protein expression in endometriosis. Hum Reprod 10:935–937

30.

Ladanyi M (2008) EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression. J Mol Diagn 10:242–248PubMedCrossRef

31.

Ichihara S, Toyooka S, Fujiwara Y et al (2007) The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer. Int J Cancer 120:1239–1247PubMedCrossRef

32.

Kim MA, Lee HS, Lee HE et al (2008) EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology 52:738–746PubMedCrossRef

Titel: Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma
verfasst von: C. Uzan
E. Darai
A. Valent
O. Graesslin
A. Cortez
R. Rouzier
P. Vielh
Publikationsdatum: 01.05.2009
Verlag: Springer-Verlag
Erschienen in: Virchows Archiv / Ausgabe 5/2009
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-009-0755-5

Springer Medizin

Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma

Abstract

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2009

Leiomyomatous nodules in a cellular angiofibroma: a hitherto unreported finding

Association of hormone receptor status with grading, age of onset, and tumor size in BRCA1-associated breast cancer

Unison or cacophony: postgraduate training in pathology in Europe

Mitochondria and cancer

Extranodular background liver parenchyma of focal nodular hyperplasia: histopathological characteristics

Biliary intraductal papillary mucinous neoplasia: three case reports

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie